ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+3.48%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$251M
AUM Growth
+$251M
(+3%)
Cap. Flow
+$4.18M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
65.61%
Holding
71
New
7
Increased
16
Reduced
10
Closed
23
Top Buys
| 1 |
Aclaris Therapeutics
ACRS
|
$10.1M |
| 2 |
Assembly Biosciences
ASMB
|
$8.05M |
| 3 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$5.74M |
| 4 |
IRIDEX
IRIX
|
$4.69M |
| 5 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$4.51M |
Top Sells
| 1 |
EVDY
Everyday Health, Inc.
EVDY
|
$11.9M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$8.71M |
| 3 |
CEMP
Cempra, Inc.
CEMP
|
$5.08M |
| 4 |
INNL
Innocoll Holdings plc Ordinary Shares
INNL
|
$3.9M |
| 5 |
Sarepta Therapeutics
SRPT
|
$3.07M |
Sector Composition
| 1 | Healthcare | 82.74% |
| 2 | Technology | 2.76% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Veracyte
VCYT
$2.39B
| $27.2M | 10.11% | 3,513,161 +368,512 | +12% | +$2.85M |
|
2
Iovance Biotherapeutics
IOVA
$807M
| $26.5M | 9.85% | 3,809,944 +580,028 | +18% | +$4.03M |
|
|
3
IRIDEX
IRIX
$22.8M
| $21.9M | 8.13% | 1,554,146 +333,535 | +27% | +$4.69M |
|
|
IMMU
4
DELISTED
Immunomedics Inc
IMMU
| $17.2M | 6.41% | 4,700,000 +850,000 | +22% | +$3.12M |
|
|
NDRM
5
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $14.8M | 5.5% | 665,944 +202,988 | +44% | +$4.51M |
|
6
PDS Biotechnology
PDSB
$57.8M
| $13M | 4.84% | 1,040,265 +337,265 | +48% | +$4.22M |
|
|
7
Assembly Biosciences
ASMB
$190M
| $11.9M | 4.41% | 976,599 +662,388 | +211% | +$8.05M |
|
8
Ascendis Pharma
ASND
$11.8B
| $11.6M | 4.33% | 575,309 +212,309 | +58% | +$4.3M |
|
|
9
Aclaris Therapeutics
ACRS
$209M
| $10.1M | 3.76% | +372,753 | New | +$10.1M |
|
10
Acadia Pharmaceuticals
ACAD
$4.38B
| $8.65M | 3.22% | 300,000 +80,000 | +36% | +$2.31M |
|
|
CEMI
11
DELISTED
Chembio diagnostics, Inc.
CEMI
| $7.83M | 2.91% | 1,150,925 +379,249 | +49% | +$2.58M |
|
12
Akebia Therapeutics
AKBA
$833M
| $7.28M | 2.71% | 698,825 -1,175 | -0.2% | -$12.2K |
|
|
OXFD
13
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.04M | 2.62% | 470,834 +63,019 | +15% | +$942K |
|
14
Marvell Technology
MRVL
$54.2B
| $6.94M | 2.58% | 500,000 -10,000 | -2% | -$139K |
|
|
CASM
15
DELISTED
CAS Medical Systems, Inc.
CASM
| $6.73M | 2.5% | 4,179,838 +334,473 | +9% | +$539K |
|
|
RARX
16
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $5.74M | 2.13% | +377,909 | New | +$5.74M |
|
|
GWPH
17
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.47M | 1.66% | 40,000 -1,487 | -4% | -$166K |
|
|
NBRV
18
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $4.21M | 1.57% | 706,383 +122,862 | +21% | +$732K |
|
|
WBMD
19
DELISTED
WebMD Health Corp.
WBMD
| $3.97M | 1.47% | 80,000 -15,000 | -16% | -$744K |
|
|
DBVT
20
DBV Technologies
DBVT
$264M
| $3.23M | 1.2% | 91,898 +35,638 | +63% | +$1.25M |
|
|
DERM
21
DELISTED
Dermira, Inc.
DERM
| $2.68M | 1% | 88,500 -18,500 | -17% | -$561K |
|
22
Vanda Pharmaceuticals
VNDA
$279M
| $2.59M | 0.96% | 162,600 -83,395 | -34% | -$1.33M |
|
|
SCTL
23
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $2.42M | 0.9% | +300,000 | New | +$2.42M |
|
24
Aurinia Pharmaceuticals
AUPH
$1.58B
| $2.1M | 0.78% | +1,000,000 | New | +$2.1M |
|
|
AERI
25
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.89M | 0.7% | 50,000 -230,000 | -82% | -$8.71M |
|